Rapid identification of cells in a clinical environment - RapidCell
Category
Instrument pretpristupne pomoći IPA (eng. Instrument for Pre-Accession assistance)
Total cost
4.790.830
Start date
Mar 1st 2013
End date
Apr 6th 2015
Status
Done
More information
Principal investigator
M
C
M
C
Basis of the RapidCell is developed method of rapid detection of peptide sequence by mass spectrometry. The method can be used for peptide/protein sequences and for accurate and fast detection of pathogens and tumor cells for use in clinical practice (ProteinAcrobate biotypization software). CAF-/CAF+ reagent enables equal peptide sequence identification in positive and negative ion mode.